Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Nishinakagawa

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Anticancer Research|August 1, 2025
Application of Nucleic Acid Medicine Using Autologous Serum-derived Small Extracellular Vesicles for Cancer MetastasisMai Hazekawa, Takuya Nishinakagawa, Daisuke Ishibashi
Pharmaceutics|April 23, 2022
Development of an Organ-Directed Exosome-Based siRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis ModelMai Hazekawa, Takuya Nishinakagawa, Masato Hosokawa, et al.
Molecular Medicine Reports|February 3, 2023
RCAS1 increases cell morphological changes in murine fibroblasts by reducing p38 phosphorylationTakuya Nishinakagawa, Mai Hazekawa, Masato Hosokawa, et al.
Journal of Pharmacological Sciences|February 27, 2019
Glypican-3 gene silencing for ovarian cancer using siRNA-PLGA hybrid micelles in a murine peritoneal dissemination modelMai Hazekawa, Takuya Nishinakagawa, Tomoyo Kawakubo-Yasukochi, et al.
Experimental and Therapeutic Medicine|September 27, 2019
Evaluation of IC<sub>50</sub> levels immediately after treatment with anticancer reagents using a real-time cell monitoring deviceMai Hazekawa, Takuya Nishinakagawa, Tomoyo Kawakubo-Yasukochi, et al.
Biological & Pharmaceutical Bulletin|March 13, 2018
In Vitro Anti-inflammatory Effects of the Phenylbutyric Acid Metabolite Phenylacetyl GlutamineMai Hazekawa, Kazuhiko Ono, Takuya Nishinakagawa, et al.
International Journal of Pharmaceutics|July 29, 2021
Enhancing the anticancer efficacy of a LL-37 peptide fragment analog using peptide-linked PLGA conjugate micelles in tumor cellsTakeshi Mori, Mai Hazekawa, Miyako Yoshida, et al.
Scientific Reports|August 19, 2021
Preparation of siRNA-PLGA/Fab'-PLGA mixed micellar system with target cell-specific recognitionMai Hazekawa, Takuya Nishinakagawa, Takeshi Mori, et al.
Experimental and Therapeutic Medicine|February 13, 2014
Sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium-induced colitis in miceKazuhiko Ono, Satoshi Nimura, Takuya Nishinakagawa, et al.
International Journal of Molecular Medicine|April 8, 2010
Analysis of cell cycle arrest and apoptosis induced by RCAS1Takuya Nishinakagawa, Sho Fujii, Tetsuya Nozaki, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Anticancer Research|August 1, 2025
Application of Nucleic Acid Medicine Using Autologous Serum-derived Small Extracellular Vesicles for Cancer MetastasisMai Hazekawa, Takuya Nishinakagawa, Daisuke Ishibashi
Pharmaceutics|April 23, 2022
Development of an Organ-Directed Exosome-Based siRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis ModelMai Hazekawa, Takuya Nishinakagawa, Masato Hosokawa, et al.
Molecular Medicine Reports|February 3, 2023
RCAS1 increases cell morphological changes in murine fibroblasts by reducing p38 phosphorylationTakuya Nishinakagawa, Mai Hazekawa, Masato Hosokawa, et al.
Journal of Pharmacological Sciences|February 27, 2019
Glypican-3 gene silencing for ovarian cancer using siRNA-PLGA hybrid micelles in a murine peritoneal dissemination modelMai Hazekawa, Takuya Nishinakagawa, Tomoyo Kawakubo-Yasukochi, et al.
Experimental and Therapeutic Medicine|September 27, 2019
Evaluation of IC<sub>50</sub> levels immediately after treatment with anticancer reagents using a real-time cell monitoring deviceMai Hazekawa, Takuya Nishinakagawa, Tomoyo Kawakubo-Yasukochi, et al.
Biological & Pharmaceutical Bulletin|March 13, 2018
In Vitro Anti-inflammatory Effects of the Phenylbutyric Acid Metabolite Phenylacetyl GlutamineMai Hazekawa, Kazuhiko Ono, Takuya Nishinakagawa, et al.
International Journal of Pharmaceutics|July 29, 2021
Enhancing the anticancer efficacy of a LL-37 peptide fragment analog using peptide-linked PLGA conjugate micelles in tumor cellsTakeshi Mori, Mai Hazekawa, Miyako Yoshida, et al.
Scientific Reports|August 19, 2021
Preparation of siRNA-PLGA/Fab'-PLGA mixed micellar system with target cell-specific recognitionMai Hazekawa, Takuya Nishinakagawa, Takeshi Mori, et al.
Experimental and Therapeutic Medicine|February 13, 2014
Sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium-induced colitis in miceKazuhiko Ono, Satoshi Nimura, Takuya Nishinakagawa, et al.
International Journal of Molecular Medicine|April 8, 2010
Analysis of cell cycle arrest and apoptosis induced by RCAS1Takuya Nishinakagawa, Sho Fujii, Tetsuya Nozaki, et al.
Pageof 3